Tivic Health Systems, Inc. (TIVC)
NASDAQ: TIVC · Real-Time Price · USD
0.249
-0.009 (-3.53%)
At close: Nov 20, 2024, 4:00 PM
0.260
+0.011 (4.46%)
Pre-market: Nov 21, 2024, 7:10 AM EST
Tivic Health Systems Employees
Tivic Health Systems had 9 employees as of December 31, 2023. The number of employees decreased by 7 or -43.75% compared to the previous year.
Employees
9
Change (1Y)
-7
Growth (1Y)
-43.75%
Revenue / Employee
$106,333
Profits / Employee
-$713,444
Market Cap
1.54M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9 | -7 | -43.75% |
Dec 31, 2022 | 16 | 9 | 128.57% |
Dec 31, 2021 | 7 | -1 | -12.50% |
Dec 31, 2020 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
China SXT Pharmaceuticals | 75 |
cbdMD | 52 |
Helius Medical Technologies | 22 |
Tenon Medical | 21 |
TFF Pharmaceuticals | 19 |
Altamira Therapeutics | 10 |
Entero Therapeutics | 9 |
SCWorx | 7 |
TIVC News
- 6 days ago - Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update - Business Wire
- 6 days ago - Tivic Health Systems, Inc. (TIVC) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device - Business Wire
- 9 days ago - Tivic Health Validates European Patents in Great Britain, Germany, and France - Business Wire
- 14 days ago - Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14 - Business Wire
- 23 days ago - First Subject Enrolled in Tivic Health's Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device - Business Wire
- 4 weeks ago - Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024 - Business Wire
- 2 months ago - Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment - Business Wire